首页 > 最新文献

Journal of Geriatric Cardiology最新文献

英文 中文
Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation. 中国心房颤动诊治指南》。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-03-28 DOI: 10.26599/1671-5411.2024.03.009
Chang-Sheng Ma, Shu-Lin Wu, Shao-Wen Liu, Ya-Ling Han

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, significantly impacting patients' quality of life and increasing the risk of death, stroke, heart failure, and dementia. Over the past two decades, there have been significant breakthroughs in AF risk prediction and screening, stroke prevention, rhythm control, catheter ablation, and integrated management. During this period, the scale, quality, and experience of AF management in China have greatly improved, providing a solid foundation for the development of guidelines for the diagnosis and management of AF. To further promote standardized AF management, and apply new technologies and concepts to clinical practice in a timely and comprehensive manner, the Chinese Society of Cardiology of the Chinese Medical Association and the Heart Rhythm Committee of the Chinese Society of Biomedical Engineering have jointly developed the Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation. The guidelines have comprehensively elaborated on various aspects of AF management and proposed the CHA2DS2-VASc-60 stroke risk score based on the characteristics of AF in the Asian population. The guidelines have also reevaluated the clinical application of AF screening, emphasized the significance of early rhythm control, and highlighted the central role of catheter ablation in rhythm control.

心房颤动(房颤)是最常见的持续性心律失常,严重影响患者的生活质量,并增加死亡、中风、心力衰竭和痴呆的风险。在过去的二十年里,房颤风险预测和筛查、中风预防、节律控制、导管消融和综合管理方面取得了重大突破。在此期间,我国心房颤动管理的规模、质量和经验都有了很大的提高,为心房颤动诊治指南的制定奠定了坚实的基础。为进一步推动房颤规范化管理,及时、全面地将新技术、新理念应用于临床实践,中华医学会心血管病学分会和中国生物医学工程学会心律专业委员会联合制定了《中国房颤诊治指南》。该指南全面阐述了心房颤动管理的各个方面,并根据亚洲人群心房颤动的特点提出了CHA2DS2-VASc-60卒中风险评分。指南还重新评估了房颤筛查的临床应用,强调了早期节律控制的重要性,并突出了导管消融在节律控制中的核心作用。
{"title":"Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation.","authors":"Chang-Sheng Ma, Shu-Lin Wu, Shao-Wen Liu, Ya-Ling Han","doi":"10.26599/1671-5411.2024.03.009","DOIUrl":"https://doi.org/10.26599/1671-5411.2024.03.009","url":null,"abstract":"<p><p>Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, significantly impacting patients' quality of life and increasing the risk of death, stroke, heart failure, and dementia. Over the past two decades, there have been significant breakthroughs in AF risk prediction and screening, stroke prevention, rhythm control, catheter ablation, and integrated management. During this period, the scale, quality, and experience of AF management in China have greatly improved, providing a solid foundation for the development of guidelines for the diagnosis and management of AF. To further promote standardized AF management, and apply new technologies and concepts to clinical practice in a timely and comprehensive manner, the Chinese Society of Cardiology of the Chinese Medical Association and the Heart Rhythm Committee of the Chinese Society of Biomedical Engineering have jointly developed the <i>Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation</i>. The guidelines have comprehensively elaborated on various aspects of AF management and proposed the CHA<sub>2</sub>DS<sub>2</sub>-VASc-60 stroke risk score based on the characteristics of AF in the Asian population. The guidelines have also reevaluated the clinical application of AF screening, emphasized the significance of early rhythm control, and highlighted the central role of catheter ablation in rhythm control.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 3","pages":"251-314"},"PeriodicalIF":2.5,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040055/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140863095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of loneliness and isolation on cardiovascular diseases: a two sample Mendelian Randomization Study. 孤独和隔离对心血管疾病的影响:双样本孟德尔随机研究。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-03-28 DOI: 10.26599/1671-5411.2024.03.006
Jia-Yin Cai, Xin Wang, Cong-Yi Zheng, Xue Cao, Zhen Hu, Run-Qing Gu, Yi-Xin Tian, Ye Tian, Lan Shao, Lin-Feng Zhang, Zeng-Wu Wang

Background: Loneliness and isolation are associated with multiple cardiovascular diseases (CVDs), but there is a lack of research on whether they were causally linked. We conducted a Mendelian Randomization (MR) study to explore causal relationships between loneliness and isolation and multiple CVDs.

Methods: Single nucleotide polymorphisms associated with loneliness and isolation were identified from a genome-wide association study (GWAS) of 455,364 individuals of European ancestry in the IEU GWAS database. Summary data for 15 CVDs were also obtained from the IEU GWAS database. We used three MR methods including inverse variance weighting, MR-Egger, and weighted median estimation to assess the causal effect of exposure on outcomes. Cochran's Q test and MR-Egger intercept test were used to evaluate the heterogeneity and pleiotropy.

Results: MR analysis showed that loneliness and isolation were significantly associated with essential hypertension (OR = 1.07, 95% CI: 1.03-1.12), atherosclerotic heart disease (OR = 1.04; 95% CI: 1.02-1.06), myocardial infarction (OR = 1.02; 95% CI: 1-1.04) and angina (OR = 1.04; 95% CI =1.02-1.06). No heterogeneity and pleiotropy effects were found in this study.

Conclusions: Causal relationship of loneliness and isolation with CVDs were found in this study.

背景:孤独和隔离与多种心血管疾病(CVDs)有关,但缺乏关于它们是否存在因果关系的研究。我们进行了一项孟德尔随机化(Mendelian Randomization,MR)研究,探讨孤独和孤立与多种心血管疾病之间的因果关系:从 IEU GWAS 数据库中 455,364 名欧洲血统个体的全基因组关联研究(GWAS)中确定了与孤独和孤立相关的单核苷酸多态性。我们还从 IEU GWAS 数据库中获得了 15 种心血管疾病的汇总数据。我们使用了三种 MR 方法(包括反方差加权法、MR-Egger 法和加权中位数估计法)来评估暴露对结果的因果效应。我们使用 Cochran's Q 检验和 MR-Egger 截距检验来评估异质性和多义性:MR分析表明,孤独和孤立与本质性高血压(OR=1.07,95% CI:1.03-1.12)、动脉粥样硬化性心脏病(OR=1.04;95% CI:1.02-1.06)、心肌梗死(OR=1.02;95% CI:1-1.04)和心绞痛(OR=1.04;95% CI=1.02-1.06)显著相关。本研究未发现异质性和多重效应:本研究发现了孤独和孤立与心血管疾病之间的因果关系。
{"title":"Effects of loneliness and isolation on cardiovascular diseases: a two sample Mendelian Randomization Study.","authors":"Jia-Yin Cai, Xin Wang, Cong-Yi Zheng, Xue Cao, Zhen Hu, Run-Qing Gu, Yi-Xin Tian, Ye Tian, Lan Shao, Lin-Feng Zhang, Zeng-Wu Wang","doi":"10.26599/1671-5411.2024.03.006","DOIUrl":"https://doi.org/10.26599/1671-5411.2024.03.006","url":null,"abstract":"<p><strong>Background: </strong>Loneliness and isolation are associated with multiple cardiovascular diseases (CVDs), but there is a lack of research on whether they were causally linked. We conducted a Mendelian Randomization (MR) study to explore causal relationships between loneliness and isolation and multiple CVDs.</p><p><strong>Methods: </strong>Single nucleotide polymorphisms associated with loneliness and isolation were identified from a genome-wide association study (GWAS) of 455,364 individuals of European ancestry in the IEU GWAS database. Summary data for 15 CVDs were also obtained from the IEU GWAS database. We used three MR methods including inverse variance weighting, MR-Egger, and weighted median estimation to assess the causal effect of exposure on outcomes. Cochran's <i>Q</i> test and MR-Egger intercept test were used to evaluate the heterogeneity and pleiotropy.</p><p><strong>Results: </strong>MR analysis showed that loneliness and isolation were significantly associated with essential hypertension (OR = 1.07, 95% CI: 1.03-1.12), atherosclerotic heart disease (OR = 1.04; 95% CI: 1.02-1.06), myocardial infarction (OR = 1.02; 95% CI: 1-1.04) and angina (OR = 1.04; 95% CI =1.02-1.06). No heterogeneity and pleiotropy effects were found in this study.</p><p><strong>Conclusions: </strong>Causal relationship of loneliness and isolation with CVDs were found in this study.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 3","pages":"340-348"},"PeriodicalIF":2.5,"publicationDate":"2024-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11040057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prognostic value of collateral circulation in coronary chronic total occlusion underwent percutaneous coronary intervention. 接受经皮冠状动脉介入治疗的冠状动脉慢性全闭塞患者侧支循环的预后价值。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.004
Xiao-Ying Hu, Wei-Xian Yang, Chang-Dong Guan, Li-Hua Xie, Ke-Fei Dou, Yong-Jian Wu, Jin-Qing Yuan, Jie Qian, Yue-Jin Yang, Shu-Bin Qiao, Lei Song

Background: The prognostic value of coronary collateral circulation (CC) in patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is underdetermined. The purpose of the study was to assess the prognostic value of current two CC grading systems and their association with long-term outcomes in patients with CTO underwent PCI.

Methods: We consecutively enrolled patients with single-vessel CTO underwent PCI between January 2010 and December 2013. All patients were categorized into well-developed or poor-developed collaterals group according to angiographic Werner's CC (grade 2 vs. grade 0-1) or Rentrop (grade 3 vs. grade 0-2) grading system. The primary endpoint was 5-year cardiac death.

Results: Of 2452 enrolled patients, the overall technical success rate was 74.1%. Well-developed collaterals were present in 686 patients (28.0%) defined by Werner's CC grade 2, and in 1145 patients (46.7%) by Rentrop grade 3. According to Werner's CC grading system, patients with well-developed collaterals had a lower rate of 5-year cardiac death compared with those with poor-developed collaterals (1.6% vs. 3.3%, P = 0.02), those with suboptimal recanalization was associated with higher rate of 5-year cardiac death compared with optimal recanalization (4.7% vs. 0.8%, P = 0.01) and failure patients (4.7% vs. 1.6%, P = 0.12). However, the similar effect was not shown in Rentrop grading system.

Conclusions: In patients with the single-vessel CTO underwent PCI, well-developed collaterals by Werner's CC definition were associated with lower rate of 5-year cardiac death. Werner's CC grading system had a greater prognostic value than Rentrop grading system in patients with CTO underwent PCI.

背景:慢性全闭塞(CTO)经皮冠状动脉介入治疗(PCI)患者冠状动脉侧支循环(CC)的预后价值尚未确定。本研究的目的是评估目前两种CC分级系统的预后价值及其与接受PCI治疗的CTO患者长期预后的关系:我们连续纳入了 2010 年 1 月至 2013 年 12 月间接受 PCI 治疗的单血管 CTO 患者。根据血管造影 Werner's CC(2 级 vs. 0-1 级)或 Rentrop(3 级 vs. 0-2 级)分级系统,所有患者均被分为发育良好或发育不良袢组。主要终点是5年心源性死亡:结果:在 2452 名入选患者中,总体技术成功率为 74.1%。686名患者(28.0%)存在韦纳CC分级2级定义的发育良好的瓣膜,1145名患者(46.7%)存在伦特洛普分级3级定义的发育良好的瓣膜。根据 Werner's CC 分级系统,瓣膜发育良好的患者与瓣膜发育不良的患者相比,5 年心脏死亡的比例较低(1.6% 对 3.3%,P = 0.02);与瓣膜再通最佳的患者(4.7% 对 0.8%,P = 0.01)和瓣膜再通失败的患者(4.7% 对 1.6%,P = 0.12)相比,瓣膜再通不理想的患者 5 年心脏死亡的比例较高。然而,在Rentrop分级系统中并未显示出类似的效果:结论:在接受 PCI 治疗的单血管 CTO 患者中,根据 Werner's CC 定义,发育良好的侧支与较低的 5 年心脏死亡率相关。在接受 PCI 治疗的 CTO 患者中,Werner CC 分级系统比 Rentrop 分级系统更有预后价值。
{"title":"The prognostic value of collateral circulation in coronary chronic total occlusion underwent percutaneous coronary intervention.","authors":"Xiao-Ying Hu, Wei-Xian Yang, Chang-Dong Guan, Li-Hua Xie, Ke-Fei Dou, Yong-Jian Wu, Jin-Qing Yuan, Jie Qian, Yue-Jin Yang, Shu-Bin Qiao, Lei Song","doi":"10.26599/1671-5411.2024.02.004","DOIUrl":"10.26599/1671-5411.2024.02.004","url":null,"abstract":"<p><strong>Background: </strong>The prognostic value of coronary collateral circulation (CC) in patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is underdetermined. The purpose of the study was to assess the prognostic value of current two CC grading systems and their association with long-term outcomes in patients with CTO underwent PCI.</p><p><strong>Methods: </strong>We consecutively enrolled patients with single-vessel CTO underwent PCI between January 2010 and December 2013. All patients were categorized into well-developed or poor-developed collaterals group according to angiographic Werner's CC (grade 2 <i>vs.</i> grade 0-1) or Rentrop (grade 3 <i>vs.</i> grade 0-2) grading system. The primary endpoint was 5-year cardiac death.</p><p><strong>Results: </strong>Of 2452 enrolled patients, the overall technical success rate was 74.1%. Well-developed collaterals were present in 686 patients (28.0%) defined by Werner's CC grade 2, and in 1145 patients (46.7%) by Rentrop grade 3. According to Werner's CC grading system, patients with well-developed collaterals had a lower rate of 5-year cardiac death compared with those with poor-developed collaterals (1.6% <i>vs.</i> 3.3%, <i>P</i> = 0.02), those with suboptimal recanalization was associated with higher rate of 5-year cardiac death compared with optimal recanalization (4.7% <i>vs.</i> 0.8%, <i>P</i> = 0.01) and failure patients (4.7% <i>vs.</i> 1.6%, <i>P</i> = 0.12). However, the similar effect was not shown in Rentrop grading system.</p><p><strong>Conclusions: </strong>In patients with the single-vessel CTO underwent PCI, well-developed collaterals by Werner's CC definition were associated with lower rate of 5-year cardiac death. Werner's CC grading system had a greater prognostic value than Rentrop grading system in patients with CTO underwent PCI.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"232-241"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between the cumulative triglyceride-glucose index and the recurrence of atrial fibrillation after radiofrequency catheter ablation. 累积甘油三酯-葡萄糖指数与射频导管消融术后心房颤动复发之间的关系。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.005
Qing Yan, Jia-Qi Liang, Yi-De Yuan, Yuan Li, Jia-Li Fan, Wen-Huan Wu, Pan Xu, Jia-Hong Xue

Background: Triglyceride-glucose (TyG) index values are a new surrogate marker for insulin resistance. This study aimed to explore the relationship between cumulative TyG index values and atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA).

Methods: A total of 576 patients with AF who underwent RFCA at the Second Affiliated Hospital of Xi'an Jiaotong University were included in this study. The participants were grouped based on cumulative TyG index values tertiles within 3 months after ablation. Cox regression and restricted cubic spline analyses were used to determine the relationship between cumulative TyG index values and AF recurrence. The predictive value of all risk factors was assessed by receiver operating curve analysis.

Results: There were 375 patients completed the study (age: 63.23 ± 10.73 years, 64.27% male). The risk of AF recurrence increased with increasing cumulative TyG index values tertiles. After adjusting for potential confounders, patients in the medium cumulative TyG index group [hazard ratio (HR) = 4.949, 95% CI: 1.778-13.778, P = 0.002] and the high cumulative TyG index group (HR = 8.716, 95% CI: 3.371-22.536, P < 0.001) had a higher risk of AF recurrence than those in the low cumulative TyG index group. The restricted cubic spline regression model also showed an increased risk of AF recurrence with increasing cumulative TyG index values. When considering cumulative TyG index values, left atrial diameter, and lactate dehydrogenase levels as a comprehensive factor, the model could effectively predict AF recurrence after RFCA [area under the curve (AUC) = 0.847, 95% CI: 0.797-0.897, P < 0.001].

Conclusions: Cumulative TyG index values were a risk factor for AF recurrence after RFCA. Monitoring longitudinal TyG index values may assist with optimized for risk stratification and outcome prediction for AF recurrence.

背景:甘油三酯-葡萄糖(TyG)指数值是胰岛素抵抗的新替代指标。本研究旨在探讨TyG指数累积值与射频导管消融术(RFCA)后房颤(AF)复发之间的关系:本研究共纳入了576名在西安交通大学第二附属医院接受射频导管消融术的房颤患者。根据消融术后3个月内的累积TyG指数值进行分组。采用Cox回归和限制性三次样条分析确定累积TyG指数值与房颤复发之间的关系。接收者操作曲线分析评估了所有风险因素的预测价值:共有 375 名患者完成了研究(年龄:63.23 ± 10.73 岁,男性占 64.27%)。房颤复发的风险随着累积TyG指数值的增加而增加。调整潜在混杂因素后,中累积TyG指数组[危险比(HR)=4.949,95% CI:1.778-13.778,P=0.002]和高累积TyG指数组(HR=8.716,95% CI:3.371-22.536,P<0.001)患者的房颤复发风险高于低累积TyG指数组。限制性三次样条回归模型也显示,随着累积 TyG 指数值的增加,房颤复发风险也会增加。当将累积TyG指数值、左心房直径和乳酸脱氢酶水平作为一个综合因素考虑时,该模型可有效预测RFCA后房颤复发[曲线下面积(AUC)= 0.847,95% CI:0.797-0.897,P < 0.001]:TyG指数累积值是RFCA后房颤复发的风险因素。监测纵向TyG指数值有助于优化房颤复发的风险分层和结果预测。
{"title":"Association between the cumulative triglyceride-glucose index and the recurrence of atrial fibrillation after radiofrequency catheter ablation.","authors":"Qing Yan, Jia-Qi Liang, Yi-De Yuan, Yuan Li, Jia-Li Fan, Wen-Huan Wu, Pan Xu, Jia-Hong Xue","doi":"10.26599/1671-5411.2024.02.005","DOIUrl":"10.26599/1671-5411.2024.02.005","url":null,"abstract":"<p><strong>Background: </strong>Triglyceride-glucose (TyG) index values are a new surrogate marker for insulin resistance. This study aimed to explore the relationship between cumulative TyG index values and atrial fibrillation (AF) recurrence after radiofrequency catheter ablation (RFCA).</p><p><strong>Methods: </strong>A total of 576 patients with AF who underwent RFCA at the Second Affiliated Hospital of Xi'an Jiaotong University were included in this study. The participants were grouped based on cumulative TyG index values tertiles within 3 months after ablation. Cox regression and restricted cubic spline analyses were used to determine the relationship between cumulative TyG index values and AF recurrence. The predictive value of all risk factors was assessed by receiver operating curve analysis.</p><p><strong>Results: </strong>There were 375 patients completed the study (age: 63.23 ± 10.73 years, 64.27% male). The risk of AF recurrence increased with increasing cumulative TyG index values tertiles. After adjusting for potential confounders, patients in the medium cumulative TyG index group [hazard ratio (HR) = 4.949, 95% CI: 1.778-13.778, <i>P</i> = 0.002] and the high cumulative TyG index group (HR = 8.716, 95% CI: 3.371-22.536, <i>P</i> < 0.001) had a higher risk of AF recurrence than those in the low cumulative TyG index group. The restricted cubic spline regression model also showed an increased risk of AF recurrence with increasing cumulative TyG index values. When considering cumulative TyG index values, left atrial diameter, and lactate dehydrogenase levels as a comprehensive factor, the model could effectively predict AF recurrence after RFCA [area under the curve (AUC) = 0.847, 95% CI: 0.797-0.897, <i>P</i> < 0.001].</p><p><strong>Conclusions: </strong>Cumulative TyG index values were a risk factor for AF recurrence after RFCA. Monitoring longitudinal TyG index values may assist with optimized for risk stratification and outcome prediction for AF recurrence.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"200-210"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of cardiometabolic multimorbidity with all-cause and cardiovascular disease mortality among Chinese hypertensive patients. 中国高血压患者的心脏代谢多病症与全因和心血管疾病死亡率的关系。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.003
Luo-Xi Xiao, Zi-Yu Wang, Jiang-Tao Li, Hai-Mei Wang, Yi-Ming Hao, Pan Zhou, Yu-Lin Huang, Qiu-Ju Deng, Yong-Chen Hao, Na Yang, Li-Zhen Han, Zhao Yang, Ping-Ping Jia, Yue Qi, Jing Liu

Background: Hypertension usually clusters with multiple comorbidities. However, the association between cardiometabolic multimorbidity (CMM) and mortality in hypertensive patients is unclear. This study aimed to investigate the association between CMM and all-cause and cardiovascular disease (CVD) mortality in Chinese patients with hypertension.

Methods: The data used in this study were from the China National Survey for Determinants of Detection and Treatment Status of Hypertensive Patients with Multiple Risk Factors (CONSIDER), which comprised 5006 participants aged 19-91 years. CMM was defined as the presence of one or more of the following morbidities: diabetes mellitus, dyslipidemia, chronic kidney disease, coronary heart disease, and stroke. Cox proportional hazard models were used to calculate the hazard ratios (HR) with 95% CI to determine the association between the number of CMMs and both all-cause and CVD mortality.

Results: Among 5006 participants [mean age: 58.6 ± 10.4 years, 50% women (2509 participants)], 76.4% of participants had at least one comorbidity. The mortality rate was 4.57, 4.76, 8.48, and 16.04 deaths per 1000 person-years in hypertensive patients without any comorbidity and with one, two, and three or more morbidities, respectively. In the fully adjusted model, hypertensive participants with two cardiometabolic diseases (HR = 1.52, 95% CI: 1.09-2.13) and those with three or more cardiometabolic diseases (HR = 2.44, 95% CI: 1.71-3.48) had a significantly elevated risk of all-cause mortality. The findings were similar for CVD mortality but with a greater increase in risk magnitude.

Conclusions: In this study, three-fourths of hypertensive patients had CMM. Clustering with two or more comorbidities was associated with a significant increase in the risk of all-cause and cardiovascular mortality among hypertensive patients, suggesting more intensive treatment and control in this high-risk patient group.

背景:高血压通常伴有多种并发症。然而,高血压患者的心脏代谢多病症(CMM)与死亡率之间的关系尚不清楚。本研究旨在调查中国高血压患者的 CMM 与全因死亡率和心血管疾病(CVD)死亡率之间的关系:本研究使用的数据来自 "中国高血压患者多重危险因素检测和治疗现状调查"(CONSIDER),该调查共有 5006 名参与者,年龄在 19-91 岁之间。CMM的定义是存在以下一种或多种疾病:糖尿病、血脂异常、慢性肾病、冠心病和脑卒中。采用 Cox 比例危险模型计算危险比(HR)和 95% CI,以确定 CMM 数量与全因死亡率和心血管疾病死亡率之间的关系:在 5006 名参与者中(平均年龄:58.6 ± 10.4 岁,50% 为女性(2509 名参与者)),76.4% 的参与者至少患有一种合并症。无任何并发症和患有一种、两种及三种或三种以上疾病的高血压患者的死亡率分别为每千人年 4.57 例、4.76 例、8.48 例和 16.04 例。在完全调整模型中,患有两种心脏代谢疾病的高血压患者(HR = 1.52,95% CI:1.09-2.13)和患有三种或三种以上心脏代谢疾病的高血压患者(HR = 2.44,95% CI:1.71-3.48)的全因死亡风险显著升高。心血管疾病死亡率的研究结果与此类似,但风险幅度增加更大:在这项研究中,四分之三的高血压患者患有CMM。患有两种或两种以上合并症的高血压患者的全因死亡和心血管疾病死亡风险显著增加,这表明对这一高风险患者群体应加强治疗和控制。
{"title":"Association of cardiometabolic multimorbidity with all-cause and cardiovascular disease mortality among Chinese hypertensive patients.","authors":"Luo-Xi Xiao, Zi-Yu Wang, Jiang-Tao Li, Hai-Mei Wang, Yi-Ming Hao, Pan Zhou, Yu-Lin Huang, Qiu-Ju Deng, Yong-Chen Hao, Na Yang, Li-Zhen Han, Zhao Yang, Ping-Ping Jia, Yue Qi, Jing Liu","doi":"10.26599/1671-5411.2024.02.003","DOIUrl":"10.26599/1671-5411.2024.02.003","url":null,"abstract":"<p><strong>Background: </strong>Hypertension usually clusters with multiple comorbidities. However, the association between cardiometabolic multimorbidity (CMM) and mortality in hypertensive patients is unclear. This study aimed to investigate the association between CMM and all-cause and cardiovascular disease (CVD) mortality in Chinese patients with hypertension.</p><p><strong>Methods: </strong>The data used in this study were from the China National Survey for Determinants of Detection and Treatment Status of Hypertensive Patients with Multiple Risk Factors (CONSIDER), which comprised 5006 participants aged 19-91 years. CMM was defined as the presence of one or more of the following morbidities: diabetes mellitus, dyslipidemia, chronic kidney disease, coronary heart disease, and stroke. Cox proportional hazard models were used to calculate the hazard ratios (HR) with 95% CI to determine the association between the number of CMMs and both all-cause and CVD mortality.</p><p><strong>Results: </strong>Among 5006 participants [mean age: 58.6 ± 10.4 years, 50% women (2509 participants)], 76.4% of participants had at least one comorbidity. The mortality rate was 4.57, 4.76, 8.48, and 16.04 deaths per 1000 person-years in hypertensive patients without any comorbidity and with one, two, and three or more morbidities, respectively. In the fully adjusted model, hypertensive participants with two cardiometabolic diseases (HR = 1.52, 95% CI: 1.09-2.13) and those with three or more cardiometabolic diseases (HR = 2.44, 95% CI: 1.71-3.48) had a significantly elevated risk of all-cause mortality. The findings were similar for CVD mortality but with a greater increase in risk magnitude.</p><p><strong>Conclusions: </strong>In this study, three-fourths of hypertensive patients had CMM. Clustering with two or more comorbidities was associated with a significant increase in the risk of all-cause and cardiovascular mortality among hypertensive patients, suggesting more intensive treatment and control in this high-risk patient group.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"211-218"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac infiltration of diffuse large B-cell lymphoma manifesting as sustained ventricular tachycardia: a case report. 弥漫大 B 细胞淋巴瘤的心脏浸润表现为持续性室性心动过速:一份病例报告。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.007
Wei Chen, Kun Huang, Wei-Wei Guo, Fan Zhou, De-Ning Liao
{"title":"Cardiac infiltration of diffuse large B-cell lymphoma manifesting as sustained ventricular tachycardia: a case report.","authors":"Wei Chen, Kun Huang, Wei-Wei Guo, Fan Zhou, De-Ning Liao","doi":"10.26599/1671-5411.2024.02.007","DOIUrl":"10.26599/1671-5411.2024.02.007","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"242-245"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chinese expert consensus on the clinical application of drug-coated balloon (2nd Edition). 药物涂层球囊临床应用中国专家共识(第二版)》。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.001
Jun-Bo Ge, Yun-Dai Chen

Percutaneous coronary interventions have progressed through the era of plain balloon dilation, bare-metal stent insertion to drug-eluting stent treatment, which has significantly reduced the acute occlusion and restenosis rates of target vessels and improved patient prognosis, making drug-eluting stents the mainstream interventional treatment for coronary artery disease. In recent years, drug-coated balloons (DCBs) have become a new treatment strategy for coronary artery disease, and the drugs used in the coating and the coating technology have progressed in the past years. Without permanent implant, a DCB delivers antiproliferative drugs rapidly and uniformly into the vessel wall via the excipient during a single balloon dilation. Many evidence suggests that DCB angioplasty is an effective measure for dealing with in-stent restenosis and de novo lesions in small coronary vessels. As more clinical studies are published, new evidence is emerging for the use of DCB angioplasty in a wide range of coronary diseases, and the indications are expanding internationally. Based on the latest research from China and elsewhere, the Expert Writing Committee of the Chinese Expert Consensus on Clinical Applications of Drug-Coated Balloon has updated the previous DCB consensus after evidence-based discussions and meetings in terms of adequate preparation of in-stent restenosis lesions, expansion of the indications for coronary de novo lesions, and precise guidance of DCB treatment by intravascular imaging and functional evaluation.

经皮冠状动脉介入治疗经历了普通球囊扩张、裸金属支架植入到药物洗脱支架治疗的时代,药物洗脱支架治疗显著降低了靶血管的急性闭塞率和再狭窄率,改善了患者的预后,使药物洗脱支架成为冠心病介入治疗的主流。近年来,药物涂层球囊(DCB)已成为冠心病的一种新的治疗策略,其涂层药物和涂层技术也在不断进步。DCB 无需永久植入,只需一次球囊扩张,就能通过辅料将抗增生药物快速、均匀地注入血管壁。许多证据表明,DCB 血管成形术是治疗支架内再狭窄和小冠状动脉新发病变的有效措施。随着更多临床研究的发表,DCB 血管成形术用于多种冠心病的新证据不断涌现,其适应症也在国际范围内不断扩大。中国药物涂层球囊临床应用专家共识》专家编写委员会根据国内及其他地区的最新研究,经过循证讨论和会议,从支架内再狭窄病变的充分准备、冠脉新生病变适应症的扩大、血管内成像和功能评价对DCB治疗的精确指导等方面,对之前的DCB共识进行了更新。
{"title":"Chinese expert consensus on the clinical application of drug-coated balloon (2<sup>nd</sup> Edition).","authors":"Jun-Bo Ge, Yun-Dai Chen","doi":"10.26599/1671-5411.2024.02.001","DOIUrl":"10.26599/1671-5411.2024.02.001","url":null,"abstract":"<p><p>Percutaneous coronary interventions have progressed through the era of plain balloon dilation, bare-metal stent insertion to drug-eluting stent treatment, which has significantly reduced the acute occlusion and restenosis rates of target vessels and improved patient prognosis, making drug-eluting stents the mainstream interventional treatment for coronary artery disease. In recent years, drug-coated balloons (DCBs) have become a new treatment strategy for coronary artery disease, and the drugs used in the coating and the coating technology have progressed in the past years. Without permanent implant, a DCB delivers antiproliferative drugs rapidly and uniformly into the vessel wall via the excipient during a single balloon dilation. Many evidence suggests that DCB angioplasty is an effective measure for dealing with in-stent restenosis and <i>de novo</i> lesions in small coronary vessels. As more clinical studies are published, new evidence is emerging for the use of DCB angioplasty in a wide range of coronary diseases, and the indications are expanding internationally. Based on the latest research from China and elsewhere, the Expert Writing Committee of the Chinese Expert Consensus on Clinical Applications of Drug-Coated Balloon has updated the previous DCB consensus after evidence-based discussions and meetings in terms of adequate preparation of in-stent restenosis lesions, expansion of the indications for coronary <i>de novo</i> lesions, and precise guidance of DCB treatment by intravascular imaging and functional evaluation.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"135-152"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal cardiac imaging assisted tumor characterization and surgical planning of a patient with rare primary cardiac paraganglioma. 多模态心脏成像辅助一名罕见原发性心脏副神经节瘤患者的肿瘤特征描述和手术规划。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.006
Shu-Yu Meng, Li-Qun Wang, Hao-Dan Dang, Lin Zhang, Sheng-Li Jiang, Bo-Han Liu
{"title":"Multimodal cardiac imaging assisted tumor characterization and surgical planning of a patient with rare primary cardiac paraganglioma.","authors":"Shu-Yu Meng, Li-Qun Wang, Hao-Dan Dang, Lin Zhang, Sheng-Li Jiang, Bo-Han Liu","doi":"10.26599/1671-5411.2024.02.006","DOIUrl":"10.26599/1671-5411.2024.02.006","url":null,"abstract":"","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"246-250"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiovascular Risk Factors in China. 中国的心血管风险因素。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.008
Sheng-Shou Hu

The Annual Report on Cardiovascular Health and Diseases in China (2022) intricate landscape of cardiovascular health in China. This section dissects cardiovascular risk factors in China which including hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease, metabolic syndrome and air pollution. Hypertension prevalence has steadily increased in China, with efforts to control it facing challenges in achieving optimal rates, especially in rural areas. Interventions like salt substitutes and intensive blood pressure control show promise but need improvement. Abnormal lipid levels, indicative of dyslipidemia, have risen significantly, posing a risk for cardiovascular diseases. Despite efforts, many patients struggle to achieve target lipid levels, necessitating improved treatment strategies. Both type 1 and type 2 diabetes mellitus affect millions of adults in China, with long-term complications adding to the disease burden. Early intervention and effective management are crucial to mitigate its impact. Prevalent among older adults, chronic kidney disease is associated with diabetes mellitus, hypertension, and cardiovascular diseases, necessitating comprehensive management approaches. The prevalence of metabolic syndrome, characterized by a cluster of risk factors, has increased in both adults and adolescents, calling for lifestyle modifications and public health interventions. Ambient and household air pollution remain significant environmental risk factors, despite some improvements in air quality. Continued efforts to reduce emissions are essential for mitigating associated health risks. Addressing these risk factors requires a multifaceted approach, including public health initiatives, policy interventions, and individual-level strategies to promote healthy lifestyles and reduce environmental exposures. Surveillance and research efforts are crucial for monitoring trends and developing effective strategies to lessen the burden of cardiovascular diseases in China.

中国心血管健康与疾病年度报告(2022)》介绍了中国心血管健康的复杂情况。本节剖析了中国的心血管风险因素,包括高血压、血脂异常、糖尿病、慢性肾病、代谢综合征和空气污染。中国的高血压患病率持续上升,控制高血压的工作面临挑战,尤其是在农村地区。盐替代品和强化血压控制等干预措施显示出前景,但仍需改进。血脂异常是血脂异常的表现,血脂异常水平显著上升,构成了心血管疾病的风险。尽管做出了努力,但许多患者仍难以达到目标血脂水平,因此有必要改进治疗策略。在中国,1 型和 2 型糖尿病影响着数百万成年人,长期并发症加重了疾病负担。早期干预和有效管理对减轻其影响至关重要。慢性肾脏病是老年人的常见病,与糖尿病、高血压和心血管疾病相关,需要采取综合治疗方法。代谢综合征是一组风险因素,在成人和青少年中的发病率都有所上升,因此需要改变生活方式和采取公共卫生干预措施。尽管空气质量有所改善,但环境和家庭空气污染仍然是重要的环境风险因素。继续努力减少排放对减轻相关的健康风险至关重要。解决这些风险因素需要采取多方面的方法,包括公共卫生倡议、政策干预和个人层面的策略,以促进健康的生活方式和减少环境暴露。监测和研究工作对于监测趋势和制定有效战略以减轻中国心血管疾病负担至关重要。
{"title":"Cardiovascular Risk Factors in China.","authors":"Sheng-Shou Hu","doi":"10.26599/1671-5411.2024.02.008","DOIUrl":"10.26599/1671-5411.2024.02.008","url":null,"abstract":"<p><p>The <i>Annual Report on Cardiovascular Health and Diseases in China</i> (2022) intricate landscape of cardiovascular health in China. This section dissects cardiovascular risk factors in China which including hypertension, dyslipidemia, diabetes mellitus, chronic kidney disease, metabolic syndrome and air pollution. Hypertension prevalence has steadily increased in China, with efforts to control it facing challenges in achieving optimal rates, especially in rural areas. Interventions like salt substitutes and intensive blood pressure control show promise but need improvement. Abnormal lipid levels, indicative of dyslipidemia, have risen significantly, posing a risk for cardiovascular diseases. Despite efforts, many patients struggle to achieve target lipid levels, necessitating improved treatment strategies. Both type 1 and type 2 diabetes mellitus affect millions of adults in China, with long-term complications adding to the disease burden. Early intervention and effective management are crucial to mitigate its impact. Prevalent among older adults, chronic kidney disease is associated with diabetes mellitus, hypertension, and cardiovascular diseases, necessitating comprehensive management approaches. The prevalence of metabolic syndrome, characterized by a cluster of risk factors, has increased in both adults and adolescents, calling for lifestyle modifications and public health interventions. Ambient and household air pollution remain significant environmental risk factors, despite some improvements in air quality. Continued efforts to reduce emissions are essential for mitigating associated health risks. Addressing these risk factors requires a multifaceted approach, including public health initiatives, policy interventions, and individual-level strategies to promote healthy lifestyles and reduce environmental exposures. Surveillance and research efforts are crucial for monitoring trends and developing effective strategies to lessen the burden of cardiovascular diseases in China.</p>","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"153-199"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plasma metabolites and risk of myocardial infarction: a bidirectional Mendelian randomization study. 血浆代谢物与心肌梗死风险:一项双向孟德尔随机研究。
IF 2.5 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-02-28 DOI: 10.26599/1671-5411.2024.02.002
Dong-Hua Li, Qiang Wu, Jing-Sheng Lan, Shuo Chen, You-Yi Huang, Lan-Jin Wu, Zhi-Qing Qin, Ying Huang, Wan-Zhong Huang, Ting Zeng, Xin Hao, Hua-Bin Su, Qiang Su
<p><strong>Background: </strong>Myocardial infarction (MI) is a critical cardiovascular event with multifaceted etiology, involving several genetic and environmental factors. It is essential to understand the function of plasma metabolites in the development of MI and unravel its complex pathogenesis.</p><p><strong>Methods: </strong>This study employed a bidirectional Mendelian randomization (MR) approach to investigate the causal relationships between plasma metabolites and MI risk. We used genetic instruments as proxies for plasma metabolites and MI and conducted MR analyses in both directions to assess the impact of metabolites on MI risk and vice versa. In addition, the large-scale genome-wide association studies datasets was used to identify genetic variants associated with plasma metabolite (1400 metabolites) and MI (20,917 individuals with MI and 440,906 individuals without MI) susceptibility. Inverse variance weighted was the primary method for estimating causal effects. MR estimates are expressed as beta coefficients or odds ratio (OR) with 95% CI.</p><p><strong>Results: </strong>We identified 14 plasma metabolites associated with the occurrence of MI (<i>P</i> < 0.05), among which 8 plasma metabolites [propionylglycine levels (OR = 0.922, 95% CI: 0.881-0.965, <i>P</i> < 0.001), gamma-glutamylglycine levels (OR = 0.903, 95% CI: 0.861-0.948, <i>P</i> < 0.001), hexadecanedioate (C16-DC) levels (OR = 0.941, 95% CI: 0.911-0.973, <i>P</i> < 0.001), pentose acid levels (OR = 0.923, 95% CI: 0.877-0.972, <i>P</i> = 0.002), X-24546 levels (OR = 0.936, 95% CI: 0.902-0.971, <i>P</i> < 0.001), glycine levels (OR = 0.936, 95% CI: 0.909-0.964, <i>P</i> < 0.001), glycine to serine ratio (OR = 0.930, 95% CI: 0.888-0.974, <i>P</i> = 0.002), and mannose to trans-4-hydroxyproline ratio (OR = 0.912, 95% CI: 0.869-0.958, <i>P</i> < 0.001)] were correlated with a decreased risk of MI, whereas the remaining 6 plasma metabolites [1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels (OR = 1.051, 95% CI: 1.018-1.084, <i>P</i> = 0.002), behenoyl dihydrosphingomyelin (d18:0/22:0) levels (OR = 1.076, 95% CI: 1.027-1.128, <i>P</i> = 0.002), 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels (OR = 1.067, 95% CI: 1.027-1.109, <i>P</i> = 0.001), alpha-ketobutyrate levels (OR = 1.108, 95% CI: 1.041-1.180, <i>P</i> = 0.001), 5-acetylamino-6-formylamino-3-methyluracil levels (OR = 1.047, 95% CI: 1.019-1.076, <i>P</i> < 0.001), and N-acetylputrescine to (N (1) + N (8))-acetylspermidine ratio (OR = 1.045, 95% CI: 1.018-1.073, <i>P</i> < 0.001)] were associated with an increased risk of MI. Furthermore, we also observed that the mentioned relationships were unaffected by horizontal pleiotropy (<i>P</i> > 0.05). On the contrary, MI did not lead to significant alterations in the levels of the aforementioned 14 plasma metabolites (<i>P</i> > 0.05 for each comparison).</p><p><strong>Conclusions: </strong>Our bidirectional MR study identified 14 plasma metabolites associated with th
背景:心肌梗死(MI)是一种严重的心血管事件,其病因是多方面的,涉及多种遗传和环境因素。了解血浆代谢物在心肌梗死发病过程中的功能并揭示其复杂的发病机制至关重要:本研究采用双向孟德尔随机化(MR)方法研究血浆代谢物与心肌梗死风险之间的因果关系。我们使用基因工具作为血浆代谢物和心肌梗死的替代物,并进行双向孟德尔随机分析,以评估代谢物对心肌梗死风险的影响,反之亦然。此外,研究人员还利用大规模全基因组关联研究数据集来确定与血浆代谢物(1400 种代谢物)和心肌梗死(20917 名心肌梗死患者和 440906 名非心肌梗死患者)易感性相关的基因变异。反方差加权是估计因果效应的主要方法。MR估计值以β系数或几率比(OR)及95% CI表示:我们发现 14 种血浆代谢物与心肌梗死的发生有关(P < 0.05),其中 8 种血浆代谢物[丙酰基甘氨酸水平(OR = 0.922,95% CI:0.881-0.965, P < 0.001)、γ-谷氨酰甘氨酸水平(OR = 0.903, 95% CI: 0.861-0.948, P < 0.001)、十六碳二酸(C16-DC)水平(OR = 0.941, 95% CI: 0.911-0.973, P < 0.001)、戊糖酸水平(OR = 0.923,95% CI:0.877-0.972,P = 0.002)、X-24546 水平(OR = 0.936,95% CI:0.902-0.971,P <0.001)、甘氨酸水平(OR = 0.936,95% CI:0.909-0.964, P < 0.001)、甘氨酸与丝氨酸比值(OR = 0.930, 95% CI: 0.888-0.974, P = 0.002)、甘露糖与反式-4-羟脯氨酸比值(OR = 0.912, 95% CI: 0.869-0.958, P < 0.001)]与心肌梗死风险降低相关,而其余 6 种血浆代谢物[1-棕榈酰-2-丙烯酰-GPE(16:0/20:4)水平(OR = 1.051,95% CI:1.018-1.084,P = 0.002)、山嵛酰基二氢鞘氨醇 (d18:0/22:0) 水平(OR = 1.076,95% CI:1.027-1.128,P = 0.002)、1-硬脂酰基-2-二十二碳六烯酰基-GPE (18:0/22:6) 水平(OR = 1.067,95% CI:1.027-1.109,P = 0.001)、α-酮丁酸水平(OR = 1.108,95% CI:1.041-1.180,P = 0.001)、5-乙酰氨基-6-甲酰氨基-3-甲基尿嘧啶水平(OR = 1.047,95% CI:1.019-1.076, P < 0.001)和 N-乙酰putrescine与(N (1) + N (8))-acetylspermidine比值(OR = 1.045, 95% CI: 1.018-1.073, P < 0.001)]与心肌梗死风险增加有关。此外,我们还观察到,上述关系不受水平多效性的影响(P > 0.05)。相反,心肌梗死并没有导致上述 14 种血浆代谢物水平的显著变化(每次比较的 P > 0.05):我们的双向磁共振研究发现了 14 种与心肌梗死相关的血浆代谢物,其中 13 种血浆代谢物以前从未报道过。这些发现为心肌梗死的早期诊断和潜在的治疗靶点提供了有价值的见解。
{"title":"Plasma metabolites and risk of myocardial infarction: a bidirectional Mendelian randomization study.","authors":"Dong-Hua Li, Qiang Wu, Jing-Sheng Lan, Shuo Chen, You-Yi Huang, Lan-Jin Wu, Zhi-Qing Qin, Ying Huang, Wan-Zhong Huang, Ting Zeng, Xin Hao, Hua-Bin Su, Qiang Su","doi":"10.26599/1671-5411.2024.02.002","DOIUrl":"10.26599/1671-5411.2024.02.002","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Myocardial infarction (MI) is a critical cardiovascular event with multifaceted etiology, involving several genetic and environmental factors. It is essential to understand the function of plasma metabolites in the development of MI and unravel its complex pathogenesis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This study employed a bidirectional Mendelian randomization (MR) approach to investigate the causal relationships between plasma metabolites and MI risk. We used genetic instruments as proxies for plasma metabolites and MI and conducted MR analyses in both directions to assess the impact of metabolites on MI risk and vice versa. In addition, the large-scale genome-wide association studies datasets was used to identify genetic variants associated with plasma metabolite (1400 metabolites) and MI (20,917 individuals with MI and 440,906 individuals without MI) susceptibility. Inverse variance weighted was the primary method for estimating causal effects. MR estimates are expressed as beta coefficients or odds ratio (OR) with 95% CI.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We identified 14 plasma metabolites associated with the occurrence of MI (&lt;i&gt;P&lt;/i&gt; &lt; 0.05), among which 8 plasma metabolites [propionylglycine levels (OR = 0.922, 95% CI: 0.881-0.965, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), gamma-glutamylglycine levels (OR = 0.903, 95% CI: 0.861-0.948, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), hexadecanedioate (C16-DC) levels (OR = 0.941, 95% CI: 0.911-0.973, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), pentose acid levels (OR = 0.923, 95% CI: 0.877-0.972, &lt;i&gt;P&lt;/i&gt; = 0.002), X-24546 levels (OR = 0.936, 95% CI: 0.902-0.971, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), glycine levels (OR = 0.936, 95% CI: 0.909-0.964, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), glycine to serine ratio (OR = 0.930, 95% CI: 0.888-0.974, &lt;i&gt;P&lt;/i&gt; = 0.002), and mannose to trans-4-hydroxyproline ratio (OR = 0.912, 95% CI: 0.869-0.958, &lt;i&gt;P&lt;/i&gt; &lt; 0.001)] were correlated with a decreased risk of MI, whereas the remaining 6 plasma metabolites [1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels (OR = 1.051, 95% CI: 1.018-1.084, &lt;i&gt;P&lt;/i&gt; = 0.002), behenoyl dihydrosphingomyelin (d18:0/22:0) levels (OR = 1.076, 95% CI: 1.027-1.128, &lt;i&gt;P&lt;/i&gt; = 0.002), 1-stearoyl-2-docosahexaenoyl-GPE (18:0/22:6) levels (OR = 1.067, 95% CI: 1.027-1.109, &lt;i&gt;P&lt;/i&gt; = 0.001), alpha-ketobutyrate levels (OR = 1.108, 95% CI: 1.041-1.180, &lt;i&gt;P&lt;/i&gt; = 0.001), 5-acetylamino-6-formylamino-3-methyluracil levels (OR = 1.047, 95% CI: 1.019-1.076, &lt;i&gt;P&lt;/i&gt; &lt; 0.001), and N-acetylputrescine to (N (1) + N (8))-acetylspermidine ratio (OR = 1.045, 95% CI: 1.018-1.073, &lt;i&gt;P&lt;/i&gt; &lt; 0.001)] were associated with an increased risk of MI. Furthermore, we also observed that the mentioned relationships were unaffected by horizontal pleiotropy (&lt;i&gt;P&lt;/i&gt; &gt; 0.05). On the contrary, MI did not lead to significant alterations in the levels of the aforementioned 14 plasma metabolites (&lt;i&gt;P&lt;/i&gt; &gt; 0.05 for each comparison).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;Our bidirectional MR study identified 14 plasma metabolites associated with th","PeriodicalId":51294,"journal":{"name":"Journal of Geriatric Cardiology","volume":"21 2","pages":"219-231"},"PeriodicalIF":2.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964012/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140307791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Geriatric Cardiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1